LOADING...

PICOT STATEMENT AND LITERATURE SEARCH

PICOT STATEMENT AND LITERATURE SEARCH

Student’s Name: Idalmis Espinosa

Institutional Affiliation: Grand Canyon University

Date: 04/23/17

EBS PROCESS

The nurses ought to measure the blood pressure of the patients depending on the evidence-based process to ensure accuracy. Accurate measurements are a crucial factor in the effective treatment of diabetes, pediatric and dialysis. The method used to measure the blood pressure in children is different from that employed in adults. In children, the process includes an auscultatory strategy that compares the results with those in the oscillometric tool.

PICOT STATEMENT

P – Population: Children about 8 to 15 years with a clinical diagnosis of diabetes, pediatric and dialysis.

I – Intervention: The subjects will be randomized to have management in different time frames of 2, 4, 6 and eight weeks.

C – Comparison: A standardized subject would be used as a control to make active comparisons. This strategy will help us to minimize effects related to not attending the clinic.

O – Outcome: Changes in the blood pressure and blood sugar level.

T – Time: The outcome would be assessed weekly for eight weeks.

Chavers, B. M., Li, S., Collins, A. J., & Herzog, C. A. (2002). Cardiovascular disease in pediatric chronic dialysis patients. Kidney international.

Global Business Assignment HelpAccording to Chavers and the rest, there is little information regarding the mortality rate of the children with diabetes and renal diseases. The study evaluated the mortality rate in children suffering from pediatric chronic dialysis. Children of ages ranging from 2 to 17 years were identified from the data system of the United States Renal Data system. A sum of 1500 children was eligible for the enclosure. 31 percent of the kids developed cardiac related diseases, while the rest developed other conditions that are related to either diabetes or pediatric dialysis. The study concluded that cardiovascular disease is the primary cause of child mortality and morbidity in pediatric chronic dialysis.

Brenner, B. M., Cooper, M. E., & Shahinfar, S. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine.

Brenner et al. contend that nephropathy is the leading source of renal disease. The researchers evaluated the function of the receptor antagonist in the type 2 diabetes patients and nephropathy. A sum of 1500 patients was randomly selected for assessment over the period of 3 years. The receptor antagonist indicated substantial benefits to the renal in the type 2 diabetes patients and nephropathy. The researchers, therefore, concluded that nephropathy could cause renal diseases that could lead to type two diabetes.

Holloway, M., Mujais, S., Kandert, M., & Warady, B. A. (2001). Pediatric Peritoneal dialysis training: characteristics and impact on peritonitis rates. Peritoneal Dialysis International.

The study was steered to regulate the effects of the training program on the peritonitis rates pediatric patients. The survey was done in 170 centers. About 600 children between the ages of 2 to 15 received the peritoneal dialysis in different centers. The results of the study indicated that the trained patients had improved conditions. As such, the researchers concluded that peritoneal dialysis training is crucial in increasing the rate of peritonitis in pediatric chronic dialysis patients.

Schröder, C. H., & European Pediatric Peritoneal Dialysis Working Group. (2003). the management of anemia in pediatric peritoneal dialysis patients. Pediatric nephrology.

Anemia is regular in constant renal disappointment. Rules for the finding and treatment of frailty in grown-up patients are accessible. The study involved the analysis of information from various journals regarding children suffering from anemia. The results should indicate that these children are at high risk of contracting diabetes, and pediatric dialysis. The researchers, therefore, recommended that the children should be given proper nutrition that protects them against anemia.

Schaefer, F., Klaus, G., Muller-Wiefel, D. E., & Mehls, O. (2009). The current practice of peritoneal dialysis in children: results of a longitudinal survey. Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). Peritoneal dialysis international,

There has been accruing epidemiological information concerning the exercise of peritoneal dialysis in kids. The researchers contend that over 200 children have been assessed since 1993. The treatment of the modalities have been regulated since 1994, the automated processes of handling the pediatric dialysis have emerged. Method endurance was 95% at three years, however, reduced to70% next five years of action, the principle explanations behind management disappointment being repetitive peritonitis, ultrafiltration disappointment, or mutually. All in all, peritoneal dialysis in youngsters, ideally executed as APD, accomplishes system survival rates like those detailed for grown-ups. Youthful children are at expanded hazard for peritonitis. The current observational PD remedy is of restricted adequacy as far as little solute and liquid evacuation.

Boehm, M., Vécsei, A., Aufricht, C., Mueller, T., Csaicsich, D., & Arbeiter, K. (2005). Risk factors for peritonitis in pediatric peritoneal dialysis: a single-center study. Pediatric Nephrology

Late US registry information and a European multicenter concentrate depicted expanded danger of diabetes in young kids on pediatric dialysis. No primary age-particular hazard variables could be characterized in these accounts. Subsequently, the researchers broke down risk components for the disease in kids regarded by PD as necessary renal substitution treatment especially looked for age-particular perspectives. Our review distinguished six risk calculates univariate investigation, specifically age. Multivariate examination identified leave site contamination and leftover pee volume as robust autonomous indicators. In outline, our review distinguished a few age-ward and age-free hazard components for the disease.

References

Boehm, M., Vécsei, A., Aufricht, C., Mueller, T., Csaicsich, D., & Arbeiter, K. (2005). Risk factors for peritonitis in pediatric peritoneal dialysis: a single-center study. Pediatric Nephrology, 20(10), 1478-1483.

Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Chavers, B. M., Li, S., Collins, A. J., & Herzog, C. A. (2002). Cardiovascular disease in pediatric chronic dialysis patients. Kidney international.

Parving, H. H., … & Shahinfar, S. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine.

Holloway, M., Mujais, S., Kandert, M., & Warady, B. A. (2001). Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates. Peritoneal Dialysis International.

Schaefer, F., Klaus, G., Muller-Wiefel, D. E., & Mehls, O. (1999). Current practice of peritoneal dialysis in children: results of a longitudinal survey. Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS). Peritoneal dialysis international, 19(Suppl 2), S445-S449.

Schröder, C. H., & European Pediatric Peritoneal Dialysis Working Group. (2003). The management of anemia in paediatric peritoneal dialysis patients. Pediatric nephrology.

Connect with us